Clinical Trials

People who work primarily in testing drug-based interventions through clinical trials.

Lawren Vandevrede, MD, PhD

Assistant Professor

As an Assistant Professor of Neurology at UCSF, Dr. Lawren Vandevrede's overarching goal is to provide outstanding clinical care to patients with dementia and their caregivers. He completed his medical training in Chicago, where he also obtained a PhD degree in neuroscience working with his mentor to develop novel therapeutic agents for the treatment of Alzheimer’s disease.

Jennifer Richards

Senior Psychometrist

Jennifer is the Senior Psychometrist of the Clinical Trials Program.

Hilary Heuer, PhD

Oculomotor Specialist

Dr. Hilary Heuer is an oculomotor specialist in the Boxer lab.

Julio Rojas-Martinez, MD, PhD

Associate Professor

Julio Rojas is a neurologist who specializes in dementia, caring for patients with cognitive difficulties or behavioral changes resulting from conditions including Alzheimer’s disease, Lewy body dementia (a form of dementia that causes cognitive defects and Parkinson’s-like symptoms), frontotemporal dementia (a common cause of dementia in younger adults that features behavioral changes) and progressive supranuclear pa

Adam Boxer, MD, PhD

Professor

Adam L. Boxer, MD, PhD, is Endowed Professor in Memory and Aging in the Department of Neurology at the University of California, San Francisco (UCSF). He directs UCSF’s Neurosciences Clinical Research Unit and the Alzheimer’s Disease and Frontotemporal Degeneration (FTD) Clinical Trials Program at the UCSF Memory and Aging Center. Dr.

Peter Ljubenkov, MD

Assistant Professor

Dr. Peter A. Ljubenkov is a behavioral neurologist at the UCSF Memory and Aging Center and specializes in caring for patients experiencing memory, language and behavioral changes due to neurological conditions, such as Alzheimer’s disease, Lewy body dementia, and other causes of dementia.

Mary Koestler, RN, PhD

Project Administrator and Trials Nurse

Mary Koestler joined the Memory and Aging Center’s clinical trials unit as project administrator and trials nurse in July 2007. Dr. Koestler completed a master’s degree in nursing with an emphasis in clinical research management at UCSF followed by a PhD degree. She currently manages industry-sponsored FDA Phase I-III Alzheimer’s disease trials. Dr. Koestler is credentialed by the Association of Clinical Research Professionals (ACRP).

Pages